Related Experiment Video

Updated: Nov 20, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.7K

Improving Therapeutic CD20 Antibodies Requires Insight into Their Mechanism of Action

Abbey B Arp1, Suraya Elfrink1, Annemiek B van Spriel1

  • 1Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Critical Reviews in Oncogenesis
|January 19, 2021
PubMed

Insights

CD20 antibodies are standard for B-cell cancers, but resistance necessitates new treatments. This review covers CD20 biology, antibody mechanisms, resistance, and novel antibody therapies for better patient outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • CD20-targeting antibodies are a cornerstone in treating mature B-cell malignancies.
  • Therapy resistance and relapse in patients treated with CD20 antibodies highlight the need for innovative therapeutic strategies.

Purpose of the Study:

  • To review the fundamental biology of the CD20 protein.
  • To elucidate the mechanisms of action for currently utilized CD20 antibodies.
  • To discuss resistance mechanisms and emerging antibody-based therapies for B-cell malignancies.

Main Methods:

  • Literature review and synthesis of existing research on CD20 biology and antibody therapeutics.
  • Analysis of mechanisms of action and resistance associated with CD20 antibodies.
  • Overview of recent advancements in novel antibody-based drug development.

Main Results:

  • CD20 antibodies function through various immune-mediated and direct cell-killing mechanisms.
  • Multiple intrinsic and extrinsic factors contribute to therapeutic resistance.
  • Novel antibody formats and combination strategies are being developed to overcome resistance.

Conclusions:

  • Understanding CD20 biology and resistance is crucial for advancing B-cell malignancy treatment.
  • Development of novel CD20-targeting antibodies and therapeutic approaches holds promise for improving patient outcomes.
  • Further research into overcoming resistance mechanisms is essential for maximizing the efficacy of antibody-based therapies.

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.0K
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
866
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.1K